Free Trial
ASX:CDY

Cellmid (CDY) Stock Price, News & Analysis

About Cellmid Stock (ASX:CDY)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CDY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cellmid and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CDY Stock News Headlines

Washington prepares for war
While the headlines obsess over overseas conflicts, Washington has been quietly preparing for something much bigger here at home. Emergency powers are being invoked, trillions are being mobilized, and the scale rivals anything we’ve seen since WWII. According to Porter Stansberry and Jeff Brown, a new economic arms race is already underway — one that could reshape markets, redirect capital, and impact billions of lives. They’ve just released an urgent briefing that explains what’s really happening behind the scenes, and which companies are positioned to benefit most.tc pixel
Hair Loss Products Market SWOT Analysis till 2030
Eastspring Investments - Japan Dynamic Fund - CDY (0P00016DXV)
See More Headlines

CDY Stock Analysis - Frequently Asked Questions

Cellmid Limited (ASX:CDY) announced its earnings results on Thursday, February, 21st. The company reported ($0.05) earnings per share (EPS) for the quarter.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cellmid investors own include Westgold Resources (WGX), WAM Research (WAX) and Credit Intelligence (CI1).

Company Calendar

Last Earnings
2/21/2019
Today
9/01/2025

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
ASX:CDY
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
13.74
Current Ratio
5.89
Quick Ratio
4.45

Sales & Book Value

Annual Sales
A$5.82 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
4.63
Book Value
A$0.06 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
220,216,992
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (ASX:CDY) was last updated on 9/1/2025 by MarketBeat.com Staff
From Our Partners